Publications by authors named "Gerd Ritter"

Claim this Profile
I
Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of cancer.
Aditi Gupta, Sadna Budhu, Kelly Fitzgerald, Rachel Giese, Adam O Michel, Gerd Ritter

Commun Biol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicological and pharmacological assessment of AGEN1884, a novel human IgG1 anti-CTLA-4 antibody.
Randi B Gombos, Ana Gonzalez, Mariana Manrique, Dhan Chand, David Savitsky, Gerd Ritter

PLoS One· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Process development for production and purification of the Schistosoma mansoni Sm14 antigen.
Leonardo Damasceno, Gerd Ritter, Carl A Batt

Protein Expr Purif· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and clinical significance of MAGE and NY-ESO-1 cancer-testis antigens in adenoid cystic carcinoma of the head and neck.
Johannes A Veit, Daniela Heine, Julia Thierauf, Jochen Lennerz, Subasch Shetty, Gerd Ritter

Head Neck· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET-based compartmental modeling of (124)I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancer.
Pat Zanzonico, Jorge A Carrasquillo, Neeta Pandit-Taskar, Joseph A O'Donoghue, John L Humm, Gerd Ritter

Eur J Nucl Med Mol Imaging· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of CTLA-4 promotes the development of effector CD8+ T lymphocytes and the therapeutic effect of vaccination with an attenuated protozoan expressing NY-ESO-1.
Luara Isabela Dos Santos, Bruno Galvão-Filho, Paula Cristina de Faria, Caroline Junqueira, Miriam Santos Dutra, Gerd Ritter

Cancer Immunol Immunother· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer.
Simon Laban, Djordje Atanackovic, Tim Luetkens, Rainald Knecht, Chia-Jung Busch, Gerd Ritter

Int J Cancer· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NY-ESO-1-specific immunological pressure and escape in a patient with metastatic melanoma.
Lotta von Boehmer, Muriel Mattle, Peter Bode, Alexandro Landshammer, Carolin Schäfer, Gerd Ritter

Cancer Immun· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rebmab200, a humanized monoclonal antibody targeting the sodium phosphate transporter NaPi2b displays strong immune mediated cytotoxicity against cancer: a novel reagent for targeted antibody therapy of cancer.
Mariana Lopes dos Santos, Fernanda Perez Yeda, Lilian Rumi Tsuruta, Bruno Brasil Horta, Alécio A Pimenta, Gerd Ritter

PLoS One· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer.
Kunle Odunsi, Junko Matsuzaki, Smitha R James, Paulette Mhawech-Fauceglia, Takemasa Tsuji, Gerd Ritter

Cancer Immunol Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of arginine deiminase treatment in melanoma xenografts using (18)F-FLT PET.
Lars Stelter, Simon Fuchs, Achim A Jungbluth, Gerd Ritter, Valerie A Longo

Mol Imaging Biol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Process development and production of cGMP grade Melan-A for cancer vaccine clinical trials.
Cameron L Bardliving, Adam J Lowe, Chung-Jr Huang, Laura Manley, Gerd Ritter

Protein Expr Purif· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy.
Anurag Gupta, Natko Nuber, Christoph Esslinger, Mareike Wittenbrink, Martin Treder, Erika Ritter, Gerd Ritter

Cancer Immun· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG protein.
Bernardo Sgarbi Reis, Achim A Jungbluth, Denise Frosina, Megan Holz, Erika Ritter, Gerd Ritter

Clin Cancer Res· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Montanide and poly-ICLC adjuvant on human self/tumor antigen-specific CD4+ T cells in phase I overlapping long peptide vaccine trial.
Takemasa Tsuji, Paul Sabbatini, Achim A Jungbluth, Erika Ritter, Linda Pan, Gerd Ritter

Cancer Immunol Res· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging of tumor vascularization using fluorescence molecular tomography to monitor arginine deiminase treatment in melanoma.
Lars Stelter, Michael J Evans, Achim A Jungbluth, Valerie A Longo, Pat Zanzonico, Gerd Ritter

Mol Imaging· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"But Dr. Old, we already have an antibody!" Reflections on Lloyd Old's "academic biotech" approach for targeted antibodies.
Gerd Ritter

Cancer Immun· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-based therapy in colorectal cancer.
Takuro Noguchi, Gerd Ritter, Hiroyoshi Nishikawa

Immunotherapy· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming regulatory T-cell suppression by a lyophilized preparation of Streptococcus pyogenes.
Michiko Hirayama, Hiroyoshi Nishikawa, Yasuhiro Nagata, Takemasa Tsuji, Takuma Kato, Gerd Ritter

Eur J Immunol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma.
Robert G Maki, Achim A Jungbluth, Sacha Gnjatic, Gary K Schwartz, David R D'Adamo, Erika Ritter, Gerd Ritter

Sarcoma· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancer.
Foluso O Ademuyiwa, Wiam Bshara, Kristopher Attwood, Carl Morrison, Stephen B Edge, Erika Ritter, Gerd Ritter

PLoS One· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients.
Paul Sabbatini, Takemasa Tsuji, Luis Ferran, Erika Ritter, Christine Sedrak, Gerd Ritter

Clin Cancer Res· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I clinical trial of mixed bacterial vaccine (Coley's toxins) in patients with NY-ESO-1 expressing cancers: immunological effects and clinical activity.
Julia Karbach, Antje Neumann, Kathrin Brand, Claudia Wahle, Ekkehard Siegel, Erika Ritter, Gerd Ritter

Clin Cancer Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trypanosoma cruzi adjuvants potentiate T cell-mediated immunity induced by a NY-ESO-1 based antitumor vaccine.
Caroline Junqueira, Ana Tereza Guerrero, Bruno Galvão-Filho, Warrison A Andrade, Ana Paula C Salgado, Gerd Ritter

PLoS One· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In silico analysis and immunohistochemical characterization of NaPi2b protein expression in ovarian carcinoma with monoclonal antibody Mx35.
Ibere Cauduro Soares, Kleber Simões, Jorge Estefano Santana de Souza, Oswaldo Keith Okamoto, Alda Wakamatsu, Gerd Ritter

Appl Immunohistochem Mol Morphol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis